18:31 Jun 19, 2013  

News

Hot Pursuit
Sharon Bio-Medicine hits lifetime high after healthy Q1 earnings
Published on Fri Nov 04, 2011 at 11:58 AM

The company announced its results after market hours on Thursday, 3 November 2011.

Meanwhile, the BSE Sensex was up 189.12 points, or 1.08% to 17,671.05.

On BSE, 39,000 shares were traded in the counter as against average daily volume of 21,612 shares in past one quarter.

The stock hit an all-time high of Rs 335 today, 4 November 2011. The stock hit a low of Rs 327 so far during the day. The stock had hit a 52-week low of Rs 130 on 9 February 2011.

The small-cap stock had outperformed the market over the past one month till 3 November 2011, rising 13.23% compared with the Sensex`s 8.24% rise. The scrip had also outperformed the market in past one quarter, gaining 28.34% as against 2.56% decline in the Sensex.

The company has an equity capital of Rs 10.56 crore. Face value per share is Rs 10.

A pharmaceuticals firm, Sharon Bio-Medicine is involved in manufacturing of intermediates, active pharmaceutical ingredients and finished dosage forms. Sharon`s long term focus is to be an integrated service provider for its customers and adding competitive advantage to its customer`s products throughout its life cycle.

Powered by Capital Market - Live News

Analyst Videos Archive
 
Fetching Data...